Ignite Creation Date:
2024-05-06 @ 2:14 AM
Last Modification Date:
2024-10-26 @ 11:15 AM
Study NCT ID:
NCT01992484
Status:
UNKNOWN
Last Update Posted:
2013-11-25
First Post:
2013-11-19
Brief Title:
Platelet Function in Patients With an Acute Coronary Syndrome
Sponsor:
Medical University of Vienna
Organization:
Medical University of Vienna
Study Overview
Official Title:
Association Between the Antiplatelet Drug EfficacySafety and Platelet Function in Patients Treated With Novel Platelet Inhibitors Due to an Acute Coronary Syndrome
Status:
UNKNOWN
Status Verified Date:
2013-11
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ATLANTIS-ACS
Brief Summary:
The aims of the study are to
explore whether platelet reactivity in patients treated wih novel platelet inhibitors is associated with clinical outcome
investigate whether a therapeutic window exist for novel platelet inhibitors
investigate the incidence of adverse events under treatment with novel platelet inhibitors in the real life clinical scenario
investigate the association between genetic polymorphisms inflammation platelet reactivity and clinical outcome
investigate synergistic effects between aspirin and novel platelet inhibitors
explore whether platelet reactivity in patients treated wih novel platelet inhibitors is associated with clinical outcome
investigate whether a therapeutic window exist for novel platelet inhibitors
investigate the incidence of adverse events under treatment with novel platelet inhibitors in the real life clinical scenario
investigate the association between genetic polymorphisms inflammation platelet reactivity and clinical outcome
investigate synergistic effects between aspirin and novel platelet inhibitors
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None